| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |